468P - A phase I, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ADCT-601 in patients with advanced solid tumours
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2019 30 Supplement 5:v176-v177 - Subject
- Language
- ISSN
- 0923-7534